Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development of cellulose-DNA immunoadsorbent.

Deling Kong1, Wolfgang Schuett, Jun Dai

  • 1Research and Development Center of Bioengineering GmbH, Teterow, Germany.

Artificial Organs
|March 7, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High glucose-primed HUVEC-derived extracellular vesicles encapsulated in microgels boost diabetic ischaemic flap regeneration via HIF-1α/VEGF pathway.

Journal of nanobiotechnology·2026
Same author

Injectable chondroitin sulfate-glycosylated decellularized extracellular matrix microgels activate Wnt/β-Catenin signaling to promote functional muscle regeneration in VML.

Bioactive materials·2026
Same author

Hierarchical microtopology and phase-specific delivery functionally restore ultralong nerve continuity across species.

Science advances·2026
Same author

Development of a vascularized multi-organoid-on-a-chip to model the heart-islet axis in diabetic cardiomyopathy.

Bioactive materials·2026
Same author

Phosphatidylserine-everted erythrocyte membrane vesicles enhance efferocytosis and remodeling of vascular grafts.

Nature communications·2026
Same author

Betaine based organ preservation solution alleviates renal allograft I/R injury by protecting endothelial cells.

Regenerative biomaterials·2026

This study developed a DNA immunoadsorbent to remove anti-DNA antibodies from patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Optimized cellulose-based adsorbents demonstrated high capacity and rapid removal of these antibodies, suggesting therapeutic potential.

Area of Science:

  • Biomedical Engineering
  • Immunology
  • Materials Science

Background:

  • Systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) are autoimmune diseases characterized by the presence of anti-DNA antibodies.
  • Current treatments for these conditions may have limitations, necessitating novel therapeutic strategies.
  • Extracorporeal removal of pathogenic antibodies offers a potential treatment modality.

Purpose of the Study:

  • To prepare a DNA immunoadsorbent for the specific, extracorporeal removal of anti-DNA antibodies.
  • To optimize the conditions for DNA coupling to cellulose beads for maximal adsorption capacity.
  • To evaluate the efficacy of the developed immunoadsorbent in removing anti-DNA antibodies from patient plasma.

Main Methods:

  • Covalent coupling of calf thymus DNA to cellulose beads using the epichlorohydrin activation method.

Related Experiment Videos

  • Optimization of activation (NaOH concentration, epichlorohydrin amount) and coupling (temperature, pH, time) conditions.
  • Batch and circulation tests using plasma from patients with SLE to assess anti-DNA antibody adsorption.
  • Main Results:

    • Optimized conditions yielded high DNA coupling capacity (over 3 mg DNA/ml wet beads).
    • Smaller cellulose beads (200-300 microm) showed excellent adsorption capacity.
    • Batch tests achieved an 80% decline in anti-DNA antibody levels, with circulation tests reaching 80% decline in 60 minutes.

    Conclusions:

    • The developed DNA immunoadsorbent demonstrates high adsorption capacity and rate for anti-DNA antibodies.
    • The optimized cellulose-based immunoadsorbent shows significant potential for the extracorporeal treatment of SLE and RA patients.
    • Further investigation into clinical applications of this immunoadsorbent is warranted.